The Conference Forum announced the launch of the 12th annual DPHARM: Disruptive Innovations to Advance Clinical Research conference, taking place September 13-14, 2022 at the Westin Copley Place in Boston, MA. DPHARM is the only conference dedicated to innovation in clinical trial operations. The 2022 theme is accelerating patient inclusivity, optionality and access.
NEW YORK, June 16, 2022 /PRNewswire-PRWeb/ -- The Conference Forum announced the launch of the 12th annual DPHARM: Disruptive Innovations to Advance Clinical Research conference, taking place September 13-14, 2022 at the Westin Copley Place in Boston, MA.
DPHARM is the only conference dedicated to innovation in clinical trial operations. The 2022 theme is accelerating patient inclusivity, optionality and access.
"We are thrilled to present an exceptional speaking faculty comprised of renowned innovation thought leaders, best-selling authors, senior clinical operations executives, patient advocates and solution providers," said Valerie Bowling, Executive Director, DPHARM.
DPHARM 2022 Keynotes and Featured Speakers include:
Scott Gottlieb, 23rd Commissioner, U.S. Food &Drug Administration addresses the future of medical innovation and the role clinical trial operations executives should be prepared for in modernizing clinical trials.
Malcolm Gladwell, renowned author of the "Tipping Point" shares his thinking on next-generation innovation and learning from the fringes.
Judy Sewards, Head of Clinical Trial Experience, Pfizer discusses leadership lessons needed to drive innovation.
Vijay Govindarajan, Coxe Distinguished Professor, Tuck School of Business, Dartmouth College and author of "Reverse Innovation" outlines how critical establishing a human-centric organization is to realizing a reverse innovation mindset.
Ezekiel J. Emanuel, MD, PhD, Vice Provost for Global Initiatives and the Diane v.S. Levy and Robert M. Levy University Professor, Co-Director of the Health Transformation Institute, University of Pennsylvania and Peter Ronco, Head of Global Development, Janssen R&D explore industry's readiness to radically change informed consent to reduce patient burden and drive greater inclusivity.
Dina Katabi, PhD, Director, IT Center for Wireless Technology, MIT demonstrates exciting capabilities in remote data monitoring and its potential to help diagnose diseases prior to symptom onset.
David Lidsky, Deputy Editor, Fast Company comments on the 50 Most Innovative Companies of 2021 and their ability to make a meaningful impact.
This year's agenda takes aim at how organizations can propel innovation by shifting organizational mindset and culture, enabling the implementation of new ideas and forging the right partners and collaborations. Presenting companies include:
J&J
Sanofi
LEO Pharma
Pfizer
AstraZeneca
BMS
Regeneron
Moderna
AbbVie
Gilead
Amgen
Merck
And more
DPHARM expects over 700 attendees from the clinical trial operations community from both US and Europe.
About DPHARM
DPHARM: Disruptive Innovations to Advance Clinical Research is the first event in the world to question how we can disrupt the way clinical research gets done to reduce the burden to patients and physicians. DPHARM has been reporting on the progress of decentralized clinical trials since 2011 and annually looks at the developments in flexible/decentralized trials with patient feedback.
About The Conference Forum
The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. The company also publishes six newsletters and produces PharmaTalkRadio, virtual events, and webinars.
Media Contact
Allyson Adams, The Conference Forum, 6462906797, [email protected]
SOURCE The Conference Forum
Share this article